The American Heart Association has named five finalists in its 8th annual Health Tech Competition, hosted by the Center for Health Technology & Innovation, addressing the critical gap between healthcare innovation and adoption for heart disease and stroke, the world's leading causes of death. The competition provides a live forum for companies to present technologies designed to prevent or treat cardiovascular conditions including high blood pressure, stroke, heart failure and related disorders.
This year's finalists include Brainomix from Oxford, England, creating AI-powered software to improve stroke diagnosis and treatment decisions; Cambrian Health from San Francisco, building an AI-powered platform that ensures clinical best practices are executed at the point of care; Lumia from Boston, delivering wearable solutions for people with orthostatic intolerance and chronic blood flow disorders; Noah Labs from Berlin, transforming voice into a digital biomarker to enable earlier intervention for cardiometabolic diseases; and PolyVascular from Houston, Texas, developing minimally invasive solutions for children with congenital heart disease to reduce the need for repeated open-heart surgeries.
The final presentations will occur during Scientific Sessions 2025, the Association's flagship global event for cardiovascular science advancements, at the New Orleans Ernest N. Morial Convention Center on November 8-9. A panel of expert volunteer judges will evaluate companies based on validity of their working prototypes, scientific rigor of validation research, and impact on improving patient outcomes through innovative technology.
The judging panel includes medical professionals, venture capitalists, and healthcare executives such as Eric D. Peterson from UT Southwestern Medical Center, Lee Shapiro from 7WireVentures, Lisa Suennen from American Heart Association Ventures, and several other distinguished experts in cardiovascular medicine and health technology. The winner will receive complimentary membership in the Center for Health Technology & Innovation Innovators' Network, a consortium connecting entrepreneurs, providers, researchers and payers to advance cardiovascular and brain health innovation.
Network membership provides significant advantages for health technology development, including collaboration opportunities for building clinical outcome study models that lower development costs, connecting science to technology, and providing evidence that digital platforms improve healthcare outcomes. Members also gain access to the American Heart Association's digital evidence-based scientific guidelines and clinical recommendations during technology development. Robert A. Harrington, M.D., volunteer chair of the Association's Health Tech Advisory Group, emphasized that the Center aims to advance rapid, efficient development of healthcare technology, with Innovators' Network membership providing opportunities to leverage consortium resources.
More information about the Health Tech competition is available at https://ahahealthtech.org/aha-health-tech-competition-2025. The Association maintains strict policies to prevent corporate donations from influencing its scientific content, with more than 85% of revenue coming from non-corporate sources including individual contributions, foundations, and investment earnings. Additional financial information is available https://www.heart.org/en/about-us/financial-information.
